查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2041766

男性腺體肥大治療市場預測——按治療方法、最終用戶和地區分類的全球分析——2034年

Gynecomastia Procedures Market Forecasts to 2034 - Global Analysis By Procedure Type (Excision, Liposuction, Mastectomy and Minimal Incision Technique), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球男性乳房增大治療市場預計到 2026 年將達到 12.219 億美元，在預測期內以 10.8% 的複合年成長率成長，到 2034 年將達到 27.756 億美元。

男性女乳症，也稱為男性乳房增大，可能由荷爾蒙失衡、某些藥物、肥胖或其他疾病引起。一種稱為男性女乳症手術的外科技術旨在透過切除多餘的乳房組織，使男性擁有更具陽剛之氣、線條更緊緻的胸部。在接受手術之前，請務必諮詢合格的整形外科醫生或其他醫療保健專業人員，以確定最適合您個人情況和預期效果的治療方案。

提高認知度和接受度

隨著人們對男性乳房肥大（GMO）的認知不斷提高，越來越多的患者開始了解治療方案。這種認知的提升，加上GMO手術需求的成長，正在推動GMO手術市場的發展。保險公司和醫療系統也可能將GMO手術納入健保範圍。醫保覆蓋範圍的擴大和資金籌措方案的出現，將使更多患者能夠負擔得起這些治療，從而可能促進市場成長。

高昂的手術費用

對於擇期手術，患者的決定很大程度取決於成本效益。過高的費用可能會阻礙男性乳房肥大患者接受手術。如果有更多人因預算困難而放棄治療，將會對市場造成衝擊。因此，高昂的治療費用導致男性乳房肥大治療機會不均等，可能會進一步加劇醫療資源分配不均的現況。對於難以獲得必要治療的社會弱勢群體和經濟困難群體而言，醫療資源分配不均的狀況可能會進一步惡化。

醫療科技的進步

隨著醫療技術的不斷進步，針對男性女乳症的新治療方法正在不斷研發。這些療法包括應用超音波能量、射頻（RF）設備和其他最尖端科技，旨在為傳統手術方法提供替代或補充方案。此外，遠端醫療和遠距會診使得偏遠地區或醫療資源匱乏地區的患者更容易獲得專家建議和諮詢。對於男性女乳症患者而言，這種支持管道的擴展改善了他們獲取資訊和治療方法方案的途徑。

文化偏見與認知

由於偏見和文化歧視，以及害怕他人看法或感到尷尬，患有男性女乳症的人可能會延遲就醫。延誤治療會加重病情，並對身心健康造成負面影響。由於缺乏對男性女乳症作為一種可治療的合法疾病的認知和了解，許多人對此並不知情，這可能導致病例漏報、手術需求下降，並阻礙市場成長。

新型冠狀病毒（COVID-19）的影響

為了集中資源救治新冠肺炎患者，疫情高峰期許多擇期手術，包括男性女乳症治療，都被延後或取消。醫院和診所被要求限制非必要手術的數量，以節省醫療資源並降低病毒傳播風險。全球醫療系統將注意力和資源從男性女乳症治療等擇期手術轉移到控制和遏制病毒傳播。

在預測期內，抽脂手術市場預計將成為最大的細分市場。

抽脂手術是治療男性女乳症（主要原因是脂肪堆積過多，導致乳房明顯增大）的常用外科手術。抽脂手術在男性女乳症治療方法市場中廣受歡迎，且成功率很高，尤其適用於脂肪堆積過多為主要原因的情況。然而，諮詢合格的整形外科醫生或其他醫療專業人員至關重要，以便根據每位患者的具體情況和預期效果選擇最佳治療方案。

預計在預測期內，整形外科中心細分市場將呈現最高的複合年成長率。

預計在預測期內，整形外科中心領域將呈現最高的複合年成長率。整形外科機構提供根據每位患者的特定需求量身定做的獨特手術方案，包括抽脂、乳房組織切除、內視鏡手術，或根據患者的具體情況採用多種技術的組合。這些診所聘請了經驗豐富的認證整形外科醫生和擅長治療男性女乳症的醫療專業人員，致力於確保最佳的治療效果、患者安全並嚴格遵守專業標準。在整個治療過程中，他們始終保持私密且專業的氛圍，並將患者的隱私和保密放在首位。

市佔率最大的地區：

預計北美將在預測期內佔據最大的市場佔有率。推動該地區市場擴張的因素包括先進的醫療基礎設施、嚴格的監管、對病人安全和醫療品質的重視，以及主要醫療機構的存在。此外，醫療機構的可近性提高和相對較高的可支配收入也使人們更容易獲得男性女乳症的治療。該領域的競爭透過促進創新和確保高標準的醫療服務，進一步鞏固了該地區的領先地位，並推動了市場成長。

複合年成長率最高的地區：

預計亞太地區在預測期內將呈現最高的複合年成長率。這主要歸功於亞太地區對男性女乳症及其治療方案的認知度不斷提高。因此，與男性女乳症相關的社會歧視正逐漸消失，人們對治療的接受度不斷提高，市場需求也進一步增強。此外，亞太地區近年來經濟成長顯著，居民可支配收入增加，也推動了該地區市場的擴張。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章：全球男性乳房肥大治療市場：依手術類型分類

  • 切除術
  • 抽脂手術
  • 切除術
  • 微創切口法

第6章：全球男性吉普賽治療市場：以最終用戶分類

  • 整形外科中心
  • 醫院

第7章 全球男性吉普賽治療市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第8章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第9章：公司簡介

  • Sun Pharmaceuticals Industries Ltd
  • Cadila Pharmaceuticals Ltd
  • Biochem Pharmaceutical Industries Ltd
  • Zydus Cadila Healthcare Ltd
  • Micro Nova Pharmaceuticals Ltd
  • Kee Pharma Ltd
  • Dr. Reddy's Laboratories Ltd
  • Vyaire Medical
  • MicroAire Surgical Instruments
  • Bausch Health Companies
  • Stryker Corporation
  • Lumenis
  • Johnson & Johnson
  • Cutera
  • GALDERMA
  • Cynosure
  • AbbVie Inc.
Product Code: SMRC24830

According to Stratistics MRC, the Global Gynecomastia Procedures Market is accounted for $1221.9 million in 2026 and is expected to reach $2775.6 million by 2034 growing at a CAGR of 10.8% during the forecast period. Gynecomastia, or male breast enlargement, can be brought on by hormone imbalances, certain drugs, obesity, or other medical disorders. Surgical techniques known as gynecomastia operations are designed to help men achieve a more manly and sculpted chest look by removing extra breast tissue. People should speak with a licensed plastic surgeon or other healthcare provider before having any operation done in order to determine the best course of action for their particular situation and desired results.

Market Dynamics:

Driver:

Increasing awareness and acceptance

As gynecomastia becomes better known, more people who are impacted by it learn about their choices for treatment. As more people seek medical intervention to address their worries about appearance and the psychological effects that go along with it, there is a greater demand for gynecomastia operations as a result of this heightened knowledge. Insurance companies and healthcare systems may change to provide coverage for gynecomastia operations. A wider group of people may find these therapies more inexpensive and accessible with improved insurance coverage or financing alternatives driving the growth of the market.

Restraint:

High procedure costs

When it comes to elective operations, patients' decisions are heavily influenced by affordability. Exorbitant expenses may cause patients to seek fewer gynecomastia operations, which would have an impact on the market if people choose not to pursue therapy because of budgetary difficulties. Thus health disparities may be exacerbated by differences in access to gynecomastia treatments brought on by exorbitant pricing. Healthcare disparities may be exacerbated for members of marginalized or economically poor populations who may find it difficult to obtain critical treatments.

Opportunity:

Advancements in medical technology

New gynecomastia treatment approaches are being investigated and developed as a result of ongoing breakthroughs in medical technology. This covers the application of ultrasonic energy, radiofrequency-assisted devices, and other cutting-edge technologies that seek to offer complementary or alternative strategies to conventional surgical techniques. Moreover, patients in rural locations or places with limited access to specialized healthcare facilities now have more access to expert views and consultations thanks to telemedicine and teleconsultation. For those with gynecomastia, this wider reach improves access to information and possible therapies.

Threat:

Cultural stigma and perception

People who are affected with gynecomastia may put off seeking medical attention out of stigma and cultural preconceptions because they are afraid of being judged or embarrassed. Delays can make the illness worse and have an adverse effect on people's physical and emotional health. Lack of knowledge or acceptance of gynecomastia as a legitimate medical problem which is a medically curable condition that many people may be unaware of, which might result in underreporting and a decline in the demand for operations thus hamper the growth of the market.

Covid-19 Impact

In order to concentrate resources for COVID-19 patients, numerous elective operations, including gynecomastia treatments, were postponed or cancelled during the height of the pandemic. In an effort to save medical resources and lower the danger of virus transmission, hospitals and clinics were instructed to restrict the number of unnecessary procedures. Global healthcare systems directed their attention and resources away from elective surgery, such as gynecomastia treatments, in order to manage and control the virus's spread.

The liposuction segment is expected to be the largest during the forecast period

The liposuction segment is estimated to have a lucrative growth, as liposuction is a popular surgical method used to treat cases where the buildup of extra fat is the main cause of male breast enlargement. Liposuction is a popular and successful method in the market for gynecomastia procedures, particularly in situations where the buildup of extra fat is the primary cause of gynecomastia. However, in order to choose the best course of action based on each patient's unique situation and desired results, it is imperative to speak with a licensed plastic surgeon or other healthcare professional.

The cosmetic surgical centers segment is expected to have the highest CAGR during the forecast period

The cosmetic surgical centers segment is anticipated to witness the highest CAGR growth during the forecast period, Cosmetic surgery facilities provide unique operations catered to the specific requirements of each customer. These might involve liposuction, excision of glandular tissue, endoscopic procedures, or a mix of methods according to the patient's condition. Board-certified cosmetic surgeons and medical professionals skilled in gynecomastia treatments work at these clinics. They guarantee the best possible results, patient safety, and professional standards compliance. Throughout the course of therapy, they keep a discreet and professional atmosphere, placing a high value on patient privacy and confidentiality.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the sophisticated healthcare infrastructure, strict regulations, focus on patient safety and quality of care and presence of important companies are the drivers driving the regional expansion. Furthermore, people can seek gynecomastia therapies more easily due to the increased accessibility to healthcare facilities and comparatively larger disposable expenditures. The rivalry in this sector further solidifies the region's supremacy by fostering innovation and ensuring a high level of treatment driving the growth of the market in this region.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to rising knowledge of gynecomastia and its treatment choices is developing in the Asia Pacific area, so the stigma associated with gynecomastia is progressively disappearing, leading to more acceptability and a stronger demand for therapies. In addition, the Asia Pacific area has had notable economic expansion in recent times, which has led to a rise in the population's disposable income, hence augmenting market expansion in the area.

Key players in the market

Some of the key players profiled in the Gynecomastia Procedures Market include Sun Pharmaceuticals Industries Ltd, Cadila Pharmaceuticals Ltd, Biochem Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Micro Nova Pharmaceuticals Ltd, Kee Pharma Ltd, Dr. Reddy's Laboratories Ltd, Vyaire Medical, MicroAire Surgical Instruments, Bausch Health Companies, Stryker Corporation, Lumenis, Johnson & Johnson, Cutera, GALDERMA, Cynosure and AbbVie Inc.

Key Developments:

In December 2023, AbbVie Inc. and Cerevel Therapeutics announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its robust neuroscience pipeline

In November 2023, Johnson & Johnson MedTech1 announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib).

In July 2023, Cadila Pharma launches Posaconazole for treatment of fungal diseases, The drug has also been recommended as a second line treatment for Mucormycosis or black fungus as it is commonly known.

Procedure Types Covered:

  • Excision
  • Liposuction
  • Mastectomy
  • Minimal Incision Technique

End Users Covered:

  • Cosmetic Surgical Centers
  • Hospitals

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gynecomastia Procedures Market, By Procedure Type

  • 5.1 Introduction
  • 5.2 Excision
  • 5.3 Liposuction
  • 5.4 Mastectomy
  • 5.5 Minimal Incision Technique

6 Global Gynecomastia Procedures Market, By End User

  • 6.1 Introduction
  • 6.2 Cosmetic Surgical Centers
  • 6.3 Hospitals

7 Global Gynecomastia Procedures Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Sun Pharmaceuticals Industries Ltd
  • 9.2 Cadila Pharmaceuticals Ltd
  • 9.3 Biochem Pharmaceutical Industries Ltd
  • 9.4 Zydus Cadila Healthcare Ltd
  • 9.5 Micro Nova Pharmaceuticals Ltd
  • 9.6 Kee Pharma Ltd
  • 9.7 Dr. Reddy's Laboratories Ltd
  • 9.8 Vyaire Medical
  • 9.9 MicroAire Surgical Instruments
  • 9.10 Bausch Health Companies
  • 9.11 Stryker Corporation
  • 9.12 Lumenis
  • 9.13 Johnson & Johnson
  • 9.14 Cutera
  • 9.15 GALDERMA
  • 9.16 Cynosure
  • 9.17 AbbVie Inc.

List of Tables

  • Table 1 Global Gynecomastia Procedures Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Gynecomastia Procedures Market Outlook, By Procedure Type (2023-2034) ($MN)
  • Table 3 Global Gynecomastia Procedures Market Outlook, By Excision (2023-2034) ($MN)
  • Table 4 Global Gynecomastia Procedures Market Outlook, By Liposuction (2023-2034) ($MN)
  • Table 5 Global Gynecomastia Procedures Market Outlook, By Mastectomy (2023-2034) ($MN)
  • Table 6 Global Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2023-2034) ($MN)
  • Table 7 Global Gynecomastia Procedures Market Outlook, By End User (2023-2034) ($MN)
  • Table 8 Global Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2023-2034) ($MN)
  • Table 9 Global Gynecomastia Procedures Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 10 North America Gynecomastia Procedures Market Outlook, By Country (2023-2034) ($MN)
  • Table 11 North America Gynecomastia Procedures Market Outlook, By Procedure Type (2023-2034) ($MN)
  • Table 12 North America Gynecomastia Procedures Market Outlook, By Excision (2023-2034) ($MN)
  • Table 13 North America Gynecomastia Procedures Market Outlook, By Liposuction (2023-2034) ($MN)
  • Table 14 North America Gynecomastia Procedures Market Outlook, By Mastectomy (2023-2034) ($MN)
  • Table 15 North America Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2023-2034) ($MN)
  • Table 16 North America Gynecomastia Procedures Market Outlook, By End User (2023-2034) ($MN)
  • Table 17 North America Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2023-2034) ($MN)
  • Table 18 North America Gynecomastia Procedures Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 19 Europe Gynecomastia Procedures Market Outlook, By Country (2023-2034) ($MN)
  • Table 20 Europe Gynecomastia Procedures Market Outlook, By Procedure Type (2023-2034) ($MN)
  • Table 21 Europe Gynecomastia Procedures Market Outlook, By Excision (2023-2034) ($MN)
  • Table 22 Europe Gynecomastia Procedures Market Outlook, By Liposuction (2023-2034) ($MN)
  • Table 23 Europe Gynecomastia Procedures Market Outlook, By Mastectomy (2023-2034) ($MN)
  • Table 24 Europe Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2023-2034) ($MN)
  • Table 25 Europe Gynecomastia Procedures Market Outlook, By End User (2023-2034) ($MN)
  • Table 26 Europe Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2023-2034) ($MN)
  • Table 27 Europe Gynecomastia Procedures Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 28 Asia Pacific Gynecomastia Procedures Market Outlook, By Country (2023-2034) ($MN)
  • Table 29 Asia Pacific Gynecomastia Procedures Market Outlook, By Procedure Type (2023-2034) ($MN)
  • Table 30 Asia Pacific Gynecomastia Procedures Market Outlook, By Excision (2023-2034) ($MN)
  • Table 31 Asia Pacific Gynecomastia Procedures Market Outlook, By Liposuction (2023-2034) ($MN)
  • Table 32 Asia Pacific Gynecomastia Procedures Market Outlook, By Mastectomy (2023-2034) ($MN)
  • Table 33 Asia Pacific Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2023-2034) ($MN)
  • Table 34 Asia Pacific Gynecomastia Procedures Market Outlook, By End User (2023-2034) ($MN)
  • Table 35 Asia Pacific Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2023-2034) ($MN)
  • Table 36 Asia Pacific Gynecomastia Procedures Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 37 South America Gynecomastia Procedures Market Outlook, By Country (2023-2034) ($MN)
  • Table 38 South America Gynecomastia Procedures Market Outlook, By Procedure Type (2023-2034) ($MN)
  • Table 39 South America Gynecomastia Procedures Market Outlook, By Excision (2023-2034) ($MN)
  • Table 40 South America Gynecomastia Procedures Market Outlook, By Liposuction (2023-2034) ($MN)
  • Table 41 South America Gynecomastia Procedures Market Outlook, By Mastectomy (2023-2034) ($MN)
  • Table 42 South America Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2023-2034) ($MN)
  • Table 43 South America Gynecomastia Procedures Market Outlook, By End User (2023-2034) ($MN)
  • Table 44 South America Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2023-2034) ($MN)
  • Table 45 South America Gynecomastia Procedures Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 46 Middle East & Africa Gynecomastia Procedures Market Outlook, By Country (2023-2034) ($MN)
  • Table 47 Middle East & Africa Gynecomastia Procedures Market Outlook, By Procedure Type (2023-2034) ($MN)
  • Table 48 Middle East & Africa Gynecomastia Procedures Market Outlook, By Excision (2023-2034) ($MN)
  • Table 49 Middle East & Africa Gynecomastia Procedures Market Outlook, By Liposuction (2023-2034) ($MN)
  • Table 50 Middle East & Africa Gynecomastia Procedures Market Outlook, By Mastectomy (2023-2034) ($MN)
  • Table 51 Middle East & Africa Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2023-2034) ($MN)
  • Table 52 Middle East & Africa Gynecomastia Procedures Market Outlook, By End User (2023-2034) ($MN)
  • Table 53 Middle East & Africa Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2023-2034) ($MN)
  • Table 54 Middle East & Africa Gynecomastia Procedures Market Outlook, By Hospitals (2023-2034) ($MN)